{"entity":{"id":"gilles-vassal","kind":"person","name":"Gilles Vassal","aka":[],"tldr":"Gustave Roussy paediatric oncologist and past SIOPE president who leads its oncopolicy work and helped shape European paediatric medicines regulation.","summary":"Gilles Vassal is a member of the SIOP Europe board responsible for oncopolicy and is Professor of Paediatric Oncology at Gustave Roussy, Villejuif. A former SIOPE president, he has been a leading advocate for the EU Paediatric Regulation and for the ACCELERATE platform to speed access to innovative medicines for children with cancer, and he founded the Innovative Therapies for Children with Cancer (ITCC) consortium.","asOf":"2026-09-10","links":[{"label":"Society page","url":"https://siope.eu/about-siope/board/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Vassal+G%5BAuthor%5D"}],"tags":["leadership","clinician-scientist","paediatric oncology","regulation"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["itcc"],"institutions":["accelerate-platform","gustave-roussy"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Board member, Oncopolicy","institutionId":"siop-europe","specialisms":["Paediatric oncology","Paediatric drug development","Oncology policy"],"profiles":[{"label":"Society page","url":"https://siope.eu/about-siope/board/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Vassal+G%5BAuthor%5D"}],"papers":[{"title":"10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers","journal":"The Lancet Oncology","year":2018,"doi":"10.1016/s1470-2045(18)30105-0"},{"title":"Do national cancer control plans address care and research for children, adolescents, and young adults? A review of status, priorities, and recommendations across 41 European countries","journal":"The Lancet Regional Health - Europe","year":2025,"doi":"10.1016/j.lanepe.2024.101155"},{"title":"Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors","journal":"European Journal of Cancer","year":2019,"doi":"10.1016/j.ejca.2018.12.031"}]},"route":"/people/gilles-vassal/","neighbours":{"company":[{"id":"itcc","kind":"company","name":"Innovative Therapies for Children with Cancer (ITCC)","route":"/companies/itcc/"}],"institution":[{"id":"accelerate-platform","kind":"institution","name":"ACCELERATE","route":"/institutions/accelerate-platform/"},{"id":"gustave-roussy","kind":"institution","name":"Gustave Roussy","route":"/institutions/gustave-roussy/"},{"id":"siop-europe","kind":"institution","name":"SIOP Europe (European Society for Paediatric Oncology)","route":"/institutions/siop-europe/"}],"person":[{"id":"nicole-scobie","kind":"person","name":"Nicole Scobie","route":"/people/nicole-scobie/"},{"id":"pamela-kearns","kind":"person","name":"Pamela Kearns","route":"/people/pamela-kearns/"}]}}